Sarah E Vititoe (Sarah Vititoe)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Quality Control

Coronavirus Disease

Clinical Practice

Top Venues

Clinical pharmacology and therapeutics

Journal of comparative effectiveness research

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Nicolle M Gatto, Sarah E Vititoe, Emily Rubinstein, Robert F Reynolds, Ulka B Campbell
A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses. Clinical pharmacology and therapeutics (2023)
Nicolle M Gatto, Sarah E Vititoe, Emily Rubinstein, Robert F Reynolds, Ulka B Campbell
A Structured Process to Identify Fit-for-purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses. Clinical pharmacology and therapeutics (2023)
Elizabeth M Garry, Andrew R Weckstein, Kenneth Quinto, Marie C Bradley, Tamar Lasky, Aloka G Chakravarty, Sandy Leonard, Sarah E Vititoe, Imaani J Easthausen, Jeremy A Rassen, Nicolle M Gatto
Categorization of COVID-19 severity to determine mortality risk. Pharmacoepidemiology and drug safety 31 (7) (2022)
Sarah E Vititoe, Imaani J Easthausen, Tamar Lasky, Aloka G Chakravarty, Marie C Bradley, Laura M Roe, Nicolle M Gatto, Andrew R Weckstein, Elizabeth M Garry
Describing characteristics and treatment patterns of patients hospitalized with COVID-19 by race and ethnicity in a national RWD during the early months of the pandemic. PloS one 17 (9) (2022)
Ashley Jaksa, James J Wu, Pall Jonsson, Hans-Georg Eichler, Sarah E Vititoe, Nicolle M Gatto
Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance. Journal of comparative effectiveness research 10 (9) (2021)